General MedicationsOTICStandard
CLOTIC
CLOTRIMAZOLE
Standard Dose
1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Prescription
Summary
Approval overview CLOTIC is listed in Drugs@FDA under application 217628 (NDA).
Review priority: PRIORITY Marketing status: Prescription Active ingredient CLOTRIMAZOLE Form and strength SOLUTION/DROPS;OTIC - 1% Sponsor CARWIN PHARM ASSOC Submission history Latest submission status date: 2025-09-26 00:00:00.
Structured Monograph
Clinical summary
Approval overview CLOTIC is listed in Drugs@FDA under application 217628 (NDA). Review priority: PRIORITY Marketing status: Prescription Active ingredient CLOTRIMAZOLE Form and strength SOLUTION/DROPS;OTIC - 1% Sponsor CARWIN PHARM ASSOC Submission history Latest submission status date: 2025-09-26 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.